Aarey Drugs & Pharmaceuticals (BOM:524412) Selling and Marketing Expense : ₹7 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Aarey Drugs & Pharmaceuticals's Selling and Marketing Expense for the three months ended in Dec. 2023 was ₹1 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹7 Mil.

Aarey Drugs & Pharmaceuticals Selling and Marketing Expense Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Selling and Marketing Expense Chart

Aarey Drugs & Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Selling and Marketing Expense

Get a 7-Day Free Trial

2.16

2.07

1.62

3.89

2.56

Aarey Drugs & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Selling and Marketing Expense	Get a 7-Day Free Trial															1.45	-1.94	6.44	1.45	0.88

Aarey Drugs & Pharmaceuticals Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7 Mil.

Aarey Drugs & Pharmaceuticals Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Selling and Marketing Expense

Traded in Other Exchanges

AAREYDRUGS:India

Address

340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009

Website

http://www.aareydrugs.com

Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines